YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY – Get Free Report) rose 1.1% during trading on Wednesday. The stock traded as high as $47.94 and last traded at $46.57. Approximately 641,189 shares changed hands during mid-day trading, an increase of 154% from the average daily volume of 252,506 shares. The stock had previously closed at $46.08.
YieldMax MRNA Option Income Strategy ETF Stock Down 2.3%
The stock has a 50-day moving average of $36.31 and a 200 day moving average of $23.68.
About YieldMax MRNA Option Income Strategy ETF
The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.
See Also
- Five stocks we like better than YieldMax MRNA Option Income Strategy ETF
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for YieldMax MRNA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YieldMax MRNA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.
